Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

IndexS&P 500 P/E33.66 EPS (ttm)6.69 Insider Own0.59% Shs Outstand72.30M Perf Week-2.32%
Market Cap16.28B Forward P/E32.07 EPS next Y7.02 Insider Trans-0.16% Shs Float71.88M Perf Month-30.52%
Income492.70M PEG6.63 EPS next Q1.22 Inst Own97.13% Short Float1.91% Perf Quarter-30.17%
Sales2.89B P/S5.63 EPS this Y-9.72% Inst Trans1.86% Short Ratio1.53 Perf Half Y-25.44%
Book/sh37.10 P/B6.07 EPS next Y15.24% ROA13.19% Short Interest1.37M Perf Year-37.26%
Cash/sh6.70 P/C33.60 EPS next 5Y5.08% ROE17.71% 52W Range197.01 - 400.88 Perf YTD-31.25%
Dividend Est.0.67 (0.30%) P/FCF58.91 EPS past 5Y15.84% ROI16.60% 52W High-43.82% Beta1.20
Dividend TTM0.82 (0.36%) Quick Ratio2.11 Sales past 5Y10.11% Gross Margin34.65% 52W Low14.31% ATR (14)10.84
Dividend Ex-DateApr 30, 2025 Current Ratio2.79 EPS Y/Y TTM-15.47% Oper. Margin20.61% RSI (14)35.52 Volatility3.41% 4.99%
Employees10600 Debt/Eq0.11 Sales Y/Y TTM-1.93% Profit Margin17.03% Recom1.64 Target Price278.00
Option/ShortYes / Yes LT Debt/Eq0.11 EPS Q/Q-2.84% Payout12.27% Rel Volume0.75 Prev Close230.77
Sales Surprise1.12% EPS Surprise5.87% Sales Q/Q2.24% EarningsFeb 13 BMO Avg Volume895.77K Price225.20
SMA20-0.14% SMA50-22.70% SMA200-26.76% Trades Volume663,296 Change-2.42%
Date Action Analyst Rating Change Price Target Change
Feb-14-25Upgrade Deutsche Bank Hold → Buy $250
Jan-08-25Initiated Citigroup Buy $400
Dec-13-24Initiated Wolfe Research Peer Perform
Dec-12-24Upgrade UBS Neutral → Buy $350 → $390
Feb-07-24Upgrade Jefferies Hold → Buy $323 → $536
Jun-16-23Upgrade BofA Securities Neutral → Buy $390 → $405
Apr-11-23Upgrade Stephens Equal-Weight → Overweight $330 → $400
Dec-14-22Initiated Deutsche Bank Hold $250
Nov-30-22Initiated UBS Neutral $250
Oct-28-22Downgrade BofA Securities Buy → Neutral $385 → $250
Mar-09-25 08:51PM
Mar-05-25 06:00AM
Feb-28-25 07:21PM
Feb-20-25 04:30PM
Feb-19-25 10:36PM
09:37AM Loading…
Feb-17-25 09:37AM
Feb-14-25 11:49AM
07:51AM
02:14AM
Feb-13-25 07:22PM
01:48PM
12:51PM
11:29AM
07:10AM
06:18AM
06:05AM Loading…
06:05AM
06:00AM
Feb-12-25 08:51AM
08:03AM
Jan-30-25 06:00AM
Jan-28-25 12:00PM
Jan-22-25 10:36AM
06:00AM
Jan-06-25 04:30PM
Dec-14-24 06:45AM
Dec-13-24 08:00AM
Dec-11-24 06:00AM
Dec-10-24 09:31AM
Nov-27-24 09:04AM
Nov-16-24 10:12AM
12:15PM Loading…
Oct-30-24 12:15PM
Oct-29-24 06:00AM
Oct-26-24 01:03AM
Oct-25-24 08:16AM
03:11AM
Oct-24-24 08:50PM
05:12PM
01:09PM
07:10AM
06:07AM
06:00AM
Oct-22-24 12:02PM
06:00AM
Oct-17-24 10:01AM
Oct-10-24 06:00AM
Oct-09-24 06:00AM
Oct-07-24 09:54PM
06:00AM
Sep-18-24 05:15PM
Sep-05-24 06:00AM
Aug-29-24 07:06PM
Aug-19-24 07:14AM
Jul-26-24 10:31AM
Jul-25-24 06:58PM
09:50AM
07:10AM
06:10AM
06:00AM
Jul-22-24 09:51AM
Jul-17-24 04:01AM
Jul-11-24 06:00AM
Jun-21-24 01:37PM
Jun-13-24 07:02PM
Jun-06-24 02:31PM
02:25PM
May-29-24 06:00AM
May-28-24 06:00AM
May-24-24 04:57AM
May-09-24 03:43PM
Apr-30-24 09:19AM
06:00AM
Apr-29-24 07:40PM
Apr-27-24 01:07AM
Apr-26-24 11:34AM
11:07AM
10:56AM
03:12AM
Apr-25-24 10:31AM
09:12AM
08:34AM
07:10AM
07:02AM
06:43AM
06:08AM
06:00AM
Apr-24-24 12:10PM
Apr-22-24 09:44AM
Apr-18-24 10:01AM
Apr-17-24 07:44AM
Apr-11-24 06:00AM
Apr-01-24 07:36AM
Mar-14-24 04:46PM
12:07PM
Mar-13-24 07:27PM
06:57AM
Mar-12-24 03:00PM
Feb-29-24 11:31PM
Feb-28-24 04:30PM
Feb-27-24 01:01PM
Feb-23-24 12:03AM
West Pharmaceutical Services, Inc. engages in the manufacture and marketing of pharmaceuticals, biologics, vaccines, and consumer healthcare products. It operates through the Proprietary Products and Contract-Manufactured Products segments. The Proprietary Products segment offers proprietary packaging, containment solutions and drug delivery products, along with analytical lab services, primarily to biologic, generic, and pharmaceutical drug customers. The Contract-Manufactured Products segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. The company was founded by Herman O. West on July 27, 1923 and is headquartered in Exton, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Birkett BernardSr VP, Chief Financial OfficerFeb 18 '25Option Exercise211.00904190,8147,669Feb 20 09:44 PM
Reiss-Clark CindyChief Commercial OfficerFeb 18 '25Option Exercise211.0024651,9405,131Feb 20 09:16 PM
MacKay Kimberly BanksSVP, GC & Corporate SecretaryFeb 18 '25Option Exercise211.0024651,9401,605Feb 20 09:13 PM
Favorite Annette FSr. VP & Chief HR OfficerFeb 18 '25Option Exercise211.0024651,9406,823Feb 20 09:11 PM
Winters ChadVP, Chief Accounting OfficerFeb 18 '25Option Exercise211.008217,3131,391Feb 20 09:09 PM
Witherspoon CharlesVP & TreasurerFeb 18 '25Option Exercise211.006613,8641,319Feb 20 09:08 PM
Green Eric MarkPresident, CEO and Board ChairFeb 18 '25Option Exercise211.002,461519,269170,369Feb 20 09:06 PM
Witherspoon CharlesVP & TreasurerOct 29 '24Option Exercise173.2247882,7991,956Oct 31 12:05 PM
Witherspoon CharlesVP & TreasurerOct 29 '24Sale310.40703218,2111,253Oct 31 12:05 PM
Abraham SiljiSVP, Chief Technology OfficerOct 29 '24Option Exercise0.0045803,318Oct 31 11:50 AM
Witherspoon CharlesVP & TreasurerAug 19 '24Option Exercise102.5152954,2282,507Aug 21 05:02 PM
Witherspoon CharlesVP & TreasurerAug 19 '24Sale300.001,029308,7001,478Aug 21 05:02 PM
Hofmann Thomas WDirectorMay 10 '24Sale365.92617225,77343,565Aug 21 04:51 PM
Green Eric MarkPresident, CEO and Board ChairAug 06 '24Option Exercise59.6436,7322,190,696192,640Aug 08 04:16 PM
Green Eric MarkPresident, CEO and Board ChairAug 06 '24Sale304.7130,7329,364,409161,898Aug 08 04:16 PM
Green Eric MarkOfficerAug 06 '24Proposed Sale304.7130,7329,364,409Aug 06 04:47 PM
Abraham SiljiSVP, Chief Technology OfficerJun 12 '24Sale330.781,800595,4042,860Jun 13 04:46 PM
Green Eric MarkPresident, CEO and Board ChairMay 07 '24Option Exercise58.8975,0004,416,500218,908May 09 03:38 PM
Green Eric MarkPresident, CEO and Board ChairMay 07 '24Sale366.6566,00024,199,050152,908May 09 03:38 PM